Navigation Links
Should men at risk for cardiovascular disease receive earlier cholesterol treatment?
Date:7/22/2014

New Rochelle, NY -- New guidelines on cholesterol treatment and cardiovascular risk assessment state that men have at least double the risk of dying from atherosclerotic cardiovascular disease or of having a heart attack or stroke as do women with a similar risk profile (based on age, smoking history, and cholesterol and blood pressure levels). The implications of this finding for when and how aggressively to treat high cholesterol are examined in an Editorial in Journal of Men's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Men's Health website at http://online.liebertpub.com/doi/full/10.1089/jomh.2014.1500 until August 22, 2014.

Stephen L. Kopecky, MD, Mayo Clinic, Rochester, MN, and Ajay Nehra, MD, Rush University Medical Center, Chicago, IL, discuss the risk factors on which the American College of Cardiology and the American Heart Association based their new guidelines. They describe the value in developing 10-year risk and lifetime risk estimates and their use in educating patients and encouraging lifestyle changes. The authors note the omission of erectile dysfunction as a risk marker, and they explain the new cholesterol treatment recommendations in the Editorial entitled "Cardiovascular Risk and Cholesterol Management in Men: Implications of the New Guidelines."


'/>"/>
Contact: Kathryn Ruehle
kruehle@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related medicine news :

1. Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why”
2. New NAT Study is Good News for Anyone with Medium-to-Severe Shoulder Pain
3. Adults with eosinophilic esophagitis should consider a diet change
4. Little League Shoulder on the Rise
5. Shoulder Fired Anti Tank Market Estimated to Reach $3.2 Billion by 2020 – New Report by MarketsandMarkets
6. The Lancet Neurology: Post-concussion return to play decision for footballers should be made solely by doctors, says new editorial
7. Stabilizing Shoulder Surgery Helps NFL Players Return to the Game
8. Intercollegiate Contact Athletes with Shoulder Instability Return to In-Season Sports, Study Shows
9. Shoulder Surgery Gets NFL Players Back in the Game
10. Nutrition screenings should be regular part of geriatric health assessment
11. Quick, easy, inexpensive cortisol testing should soon be available on all smartphones
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Should men at risk for cardiovascular disease receive earlier cholesterol treatment?
(Date:7/21/2017)... NEW ORLEANS, La. (PRWEB) , ... July 21, ... ... tool to allow 4th-year medical students improve their chances of acceptance to a ... particularly for those who have earned degrees outside the U.S. , According to ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne is proud of ... her research center at Bio-Logic Aqua Research® Water Life Science®, has been released ... of sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... with over 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome ... knee-related quality of life a decade after surgery, though activity levels decline over ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... insight into why concussion rates are on the rise, say researchers presenting their ... today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns of ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... company focused on the development of oral drug delivery systems, ... Securities Authority to dual-list its common stock on the Tel ... on the TASE on July 12, 2017 under the ticker ... it is expected that Oramed will be included in the ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: